Replies to post #121170 on Biotech Values

[DewDiligence]

NEOP—if approval is likely, a 40% haircut in 3 days is a bit overdone IMO.

Not necessarily; the enterprise value of $350M+ remains bloated, IMO. The stock has been heavily pumped in the past few months, not only by posters on iHub, but also by one of NEOP’s non-executive directors. Insiders are now selling.